Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
Takahiro Ishiguro, Yuji Sano, Shunichiro Komatsu, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 410
Open Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn, Maarten L. Janmaat, Janice M. Reichert, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 8, pp. 585-608
Closed Access | Times Cited: 1002
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Nikos K. Karamanos, Zoi Piperigkou, Achilleas D. Theocharis, et al.
Chemical Reviews (2018) Vol. 118, Iss. 18, pp. 9152-9232
Closed Access | Times Cited: 296
A review of bispecific antibodies and antibody constructs in oncology and clinical challenges
Frans V. Suurs, Marjolijn N. Lub–de Hooge, Elisabeth G.E. de Vries, et al.
Pharmacology & Therapeutics (2019) Vol. 201, pp. 103-119
Open Access | Times Cited: 245
Bispecific Antibodies: From Research to Clinical Application
Jiabing Ma, Yicheng Mo, Menglin Tang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 235
Immunotherapy for hepatocellular carcinoma
Zongyi Yin, Xiaowu Li
Cancer Letters (2019) Vol. 470, pp. 8-17
Closed Access | Times Cited: 218
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation
Lan Wu, Edward Seung, Ling Xu, et al.
Nature Cancer (2019) Vol. 1, Iss. 1, pp. 86-98
Closed Access | Times Cited: 190
Recent advances in systemic therapy for hepatocellular carcinoma
Huajun Zhang, Wuyang Zhang, Longying Jiang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 166
The landscape of bispecific T cell engager in cancer treatment
Yingtang Zhou, Ming‐Guo Liu, Fei Ren, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 159
Current landscape and future directions of bispecific antibodies in cancer immunotherapy
Jing Wei, Yueyao Yang, Gang Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 104
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
Xiufeng Zheng, Xun Liu, Yanna Lei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 89
Engineering MMP-2 Activated Nanoparticles Carrying B7-H3 Bispecific Antibodies for Ferroptosis-Enhanced Glioblastoma Immunotherapy
Rangrang Fan, Caili Chen, Min Mu, et al.
ACS Nano (2023) Vol. 17, Iss. 10, pp. 9126-9139
Closed Access | Times Cited: 56
Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
Deep Shah, Brian W. Soper, Lindsay S. Shopland
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49
DNA framework signal amplification platform-based high-throughput systemic immune monitoring
Ye Chen, Xingyu Chen, Bowen Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
Meng Guo, Hailing Zhang, Jianming Zheng, et al.
Journal of Cancer (2020) Vol. 11, Iss. 8, pp. 2008-2021
Open Access | Times Cited: 134
Antibody therapeutics and immunoregulation in cancer and autoimmune disease
Masahiro Yasunaga
Seminars in Cancer Biology (2019) Vol. 64, pp. 1-12
Open Access | Times Cited: 133
Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice
Dan Li, Nan Li, Yifan Zhang, et al.
Gastroenterology (2020) Vol. 158, Iss. 8, pp. 2250-2265.e20
Open Access | Times Cited: 126
Glypicans as Cancer Therapeutic Targets
Nan Li, Wei Gao, Yifan Zhang, et al.
Trends in cancer (2018) Vol. 4, Iss. 11, pp. 741-754
Open Access | Times Cited: 125
Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
Takahiro Nishida, Hiroaki Kataoka
Cancers (2019) Vol. 11, Iss. 9, pp. 1339-1339
Open Access | Times Cited: 117
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Yasuhiro Shimizu, Toshihiro Suzuki, Toshiaki Yoshikawa, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 110
Targets and Antibody Formats for Immunotherapy of Neuroblastoma
Jeong A Park, Nai‐Kong V. Cheung
Journal of Clinical Oncology (2020) Vol. 38, Iss. 16, pp. 1836-1848
Open Access | Times Cited: 107
Recent developments with immunotherapy for hepatocellular carcinoma
Oliver Waidmann
Expert Opinion on Biological Therapy (2018) Vol. 18, Iss. 8, pp. 905-910
Closed Access | Times Cited: 105
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
Bushra Husain, Diego Ellerman
BioDrugs (2018) Vol. 32, Iss. 5, pp. 441-464
Open Access | Times Cited: 96
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
Sebastian Kobold, Stanislav Pantelyushin, Felicitas Rataj, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 90
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
Cheng‐Tao Jiang, Kaige Chen, An Liu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 90
Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
Hans‐Heinrich Oberg, Christian Kellner, Daniel Gonnermann, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top